ROBERT HALF REPORTS FOURTH-QUARTER FINANCIAL RESULTS

Robert Half Inc. (NYSE: RHI) today reported revenues and earnings for the fourth quarter ended December 31, 2024. https://mma.prnewswire.com/media/2188927/Robert_Half_v2_Logo.jpg For the three months ended December31, 2024, net income was $54 million, or $0.53 per share, on revenues of $1.382 billion. For the three months ended December31, 2023, net income was $87 million, or $0.83 per […]

Microsoft earnings press release available on Investor Relations website

Microsoft Corp. on Wednesday announced that fiscal year 2025 second-quarter financial results are available on its Investor Relations website. The direct link to the earnings press release is https://www.microsoft.com/en-us/Investor/earnings/FY-2025-Q2/press-release-webcast. https://mma.prnewswire.com/media/1702517/Microsoft_Company_Logo.jpg As previously announced, the company will host a conference call at 2:30 p.m. Pacific Time. A live webcast of the call can be accessed on

Lam Research Corporation Reports Financial Results for the Quarter Ended December 29, 2024

Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended December 29, 2024 (the “December 2024 quarter”). Highlights for the December 2024 quarter were as follows: — Revenue of $4.38 billion. — U.S. GAAP gross margin of 47.4%, U.S. GAAP operating income as a percentage of revenue of 30.5%,

Resideo to Release Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, will release fourth quarter and full year 2024 financial results after the close of the New York Stock Exchange on Thursday, February 20, 2025. A conference call and simultaneous webcast

Washington Trust Reports Fourth Quarter and Full-Year 2024 Results

Washington Trust Bancorp, Inc. (the “Corporation”) (Nasdaq: WASH), parent company of The Washington Trust Company (the “Bank”), today reported a fourth quarter 2024 net loss of $60.8 million, or a $3.46 loss per diluted share. Excluding the impact of the balance sheet repositioning sale transactions described below, adjusted net income (non-GAAP) for the fourth quarter

Century Communities Reports Fourth Quarter and Full Year 2024 Results

Fourth Quarter Net Income Increased 13% YoY to $102.7 Million, or $3.20 Per Diluted Share – – Fourth Quarter Adjusted Net Income Increased 18% YoY to $112.0 Million, or $3.49 Per Diluted Share – – Full Year Deliveries Increased 15% YoY to a Company Record 11,007 – – Book Value per Share Increased 13% YoY

Las Vegas Sands Reports Fourth Quarter 2024 Results

For the quarter ended December 31, 2024 (Compared to the quarter ended December 31, 2023) — Net Revenue of $2.90 billion and Net Income of $392 million — Consolidated Adjusted Property EBITDA of $1.11 billion — Macao Adjusted Property EBITDA of $571 million — Low Hold on Rolling Play in Macao Negatively Impacted Adjusted Property

Whirlpool Announces Fourth-Quarter and Full-Year Results; Provides 2025 Guidance

Fourth-quarter net sales decline of (18.7)% due to the Europe divestiture; organic net sales(1) growth of 1.9% driven by strong small domestic appliances and international businesses Delivered approximately $300 million of net cost take out in 2024, as expected Q4 GAAP net earnings margin (loss) of (9.5)%; GAAP earnings (loss) per diluted share of $(7.10)

Noble Corporation plc to announce fourth quarter and full year 2024 results

Noble Corporation plc (“Noble” or the “Company”) (NYSE: NE) today announces plans to report financial results for the fourth quarter and full year 2024 on Monday February 17, 2025 after the U.S. market close. The Company's earnings press release and accompanying earnings presentation will be available on the Noble website at www.noblecorp.com. Noble will host

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today the appointment ofAdele Gulfo to its Board of Directors. Ms. Gulfo brings nearly three decades of executive leadership experience to the TYRA board, with a strong track

Scroll to Top